Rapamycin: Brain excitability studied in vitro

Epilepsia

Volumn 48, Issue 4, 2007, Pages 834-836

  Daoud, Delchad ^a   Scheld, Hans H ^b   Speckmann, Erwin Josef ^a   Gorji, Ali ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b Klinik und Poliklinik fur Anasthesiologie und Operative Intensivmedizin   (Germany)

Author keywords

Immunosuppressive therapy; Neuronal excitability; Neurotoxicity; Seizure; Transplantation

Indexed keywords

RAPAMYCIN; TACROLIMUS;

ANIMAL TISSUE; ARTICLE; BIOENERGY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; EPILEPTIC DISCHARGE; HIPPOCAMPUS; IN VITRO STUDY; NERVE CELL EXCITABILITY; NEUROTOXICITY; NONHUMAN; POSTSYNAPTIC POTENTIAL; PRIORITY JOURNAL; RAT;

ANIMALS; BRAIN; CALCINEURIN; DOSE-RESPONSE RELATIONSHIP, DRUG; EPILEPSY; EVOKED POTENTIALS; EXCITATORY POSTSYNAPTIC POTENTIALS; GRAFT REJECTION; HIPPOCAMPUS; IMMUNOSUPPRESSIVE AGENTS; NEURONS; NEUROTOXICITY SYNDROMES; RATS; SEIZURES; SIROLIMUS; TACROLIMUS; TRANSPLANTATION;

EID: 34247111348     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1167.2006.00976.x     Document Type: Article

References (17)

1. Butcher SP, Henshall DC, Teramura Y, Iwasaki K, Sharkey J. (1997) Neuroprotective actions of FK506 in experimental stroke: in vivo evidence against an antiexcitotoxic mechanism. Journal of Neuroscience 17:6939-6946.
2. Calne RY, Collier DS, Lim S, Pollard SG, Samaan A, White DJ, Thiru S. (1989) Rapamycin for immunosuppression in organ allografting. Lancet 2:227.
3. Diekmann F, Gutierrez-Dalmau A, Torregrosa JV, Oppenheimer F, Campistol JM. (2005) Sirolimus monotherapy: feasible immunosuppression for long-term follow-up of kidney transplantation - a pilot experience. Transplantation 80:1344-1348.
4. Geoerger B, Kerr K, Tang CB, Fung KM, Powell B, Sutton LN, Phillips PC, Janss AJ. (2001) Antitumor activity of the rapamycin analog CCI-779 in human primitive neuroectodermal tumor/medulloblastoma models as single agent and in combination chemotherapy. Cancer Research 61:1527-1532.
5. Gorji A, Scheld HH, Speckmann EJ. (2002) Epileptogenic effect of cyclosporine in guinea-pig hippocampal slices. Neuroscience 115:993-997.
6. Hodges CB, Maxwell H, Beattie TJ, Murphy AV, Jindal RM. (2001) Use of rapamycin in a transplant patient who developed cyclosporin neurotoxicity. Pediatric Nephrology 16:777-778.
7. Karpova A, Mikhaylova M, Thomas U, Knopfel T, Behnisch T. (2006) Involvement of protein synthesis and degradation in long-term potentiation of Schaffer collateral CA1 synapses. Journal of Neuroscience 26:4949-4955.
8. Maramattom BV, Wijdicks EF. (2004) Sirolimus may not cause neurotoxicity in kidney and liver transplant recipients. Neurology 63:1958-1959.
9. Martel RR, Klicius J, Galet S. (1977) Inhibition of the immune response by rapamycin, a newantifungal antibiotic. Canadian Journal of Physiology and Pharmacology 55:48-51.
10. Oellerich M, Armstrong VW, Schutz E, Shaw LM. (1998) Therapeutic drug monitoring of cyclosporine and tacrolimus. Update on Lake Louise Consensus Conference on cyclosporin and tacrolimus. Clinical Biochemistry 31:309-316.
11. Ponticelli C, Campise MR. (2005) Neurological complications in kidney transplant recipients. Journal of Nephrology 18:521-528.
12. Sehgal SN. (2003) Sirolimus: its discovery, biological properties, and mechanism of action. Transplantation Proceedings 35(suppl 3):S7-S14.
13. Serkova N, Christians U, Flogel U, Pfeuffer J, Leibfritz D. (1997) Assessment of the mechanism of astrocyte swelling induced by the macrolide immunosuppressant sirolimus using multinuclear nuclear magnetic resonance spectroscopy. Chemical Research in Toxicology 10:1359-1363.
14. Sheth KN, Wu GF, Messe SR, Wolf RL, Kasner SE. (2003) Dialysis disequilibrium: another reversible posterior leukoencephalopathy syndrome? Clinical Neurology and Neurosurgery 105:249-252.
15. Snyder SH, Lai MM, Burnett PE. (1998) Immunophilins in the nervous system. Neuron 21:283-294.
16. Terashima A, Taniguchi T, Nakai M, Yasuda M, Kawamata T, Tanaka C. (2000) Rapamycin and FK506 induce long-term potentiation by pairing stimulation via an intracellular Ca(2+) signaling mechanism in rat hippocampal CA1 neurons. Neuropharmacology 39:1920-1928.
17. Yakel JL. (1997) Calcineurin regulation of synaptic function: from ion channels to transmitter release and gene transcription. Trends in Pharmacological Sciences 18:124-134.